A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
about
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A randomised, double-blind tri ...... h active rheumatoid arthritis.
@en
type
label
A randomised, double-blind tri ...... h active rheumatoid arthritis.
@en
prefLabel
A randomised, double-blind tri ...... h active rheumatoid arthritis.
@en
P2093
P2860
P1476
A randomised, double-blind tri ...... h active rheumatoid arthritis.
@en
P2093
Alan Kivitz
Andra Balanescu
Juan Gomez-Reino
Morton Scheinberg
Peijuan Zhu
Stanley B Cohen
Tamas Shisha
P2860
P304
P356
10.1136/ANNRHEUMDIS-2017-211281
P407
P577
2017-06-21T00:00:00Z